Abstract
e17021 Background: To evaluate efficacy and toxicity of cetuximab plus cisplatin in recurrent or metastatic undifferentiated carcinoma of nasopharyngeal type (UCNT) after previous platinum based ch...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
